1-15 of 74
Emerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
CME/CE Broadcast ReplayEmerging Focus in NAION: Sharpening Diagnostic Precision for Tomorrow’s Treatments
Prem S. Subramanian, MD, PhD
Andrew G. Lee, MD
Valerie Biousse, MD
- CME/CE In-Person & Virtual Event
Treating Outside the Box: New Pathways to Retinal Vascular Stability
July 17, 2026
Montreal Enhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
CME/CE Broadcast ReplayEnhancing Collaborative Care in Retinal Diseases: A Focus on Injection Therapies
Deepak Sambhara, MD
Overcoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEOvercoming Cultural and Communication Disconnects, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Chin Yee, MD, FASRS
A Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEA Case of Missed Diagnosis, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Esther Lee Kim, MD
Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEPatient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
Deepak Sambhara, MD
- advertisement
It Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
CME/CEIt Takes a Village, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
David Eichenbaum, MD
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CEAddressing Unmet Needs in Metastatic Uveal Melanoma
Marlana Orloff, MD
Gregory Daniels, MD, PhD
Jesse Keller, MD
Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice
MinuteCE®Patient-Centered Care and Integration of Photobiomodulation Therapy into Clinical Practice
Diana V. Do, MD
Marion Munk, MD, Ph.D
Janis T. Eells, Ph.D.
David Boyer, MD
Diana V. Do, MD
Marion Munk, MD, Ph.D
Clinical and Safety Outcomes from the LIGHTSITE III Trial
MinuteCE®Clinical and Safety Outcomes from the LIGHTSITE III Trial
David Boyer, MD
Diana V. Do, MD
Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection
MinuteCE®Best Practices for Optimized Photobiomodulation Treatment Effect: Candidate Selection
Marion Munk, MD, Ph.D
Diana V. Do, MD
- advertisement
Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
MinuteCE®Photobiomodulation: A Non-Invasive Treatment for Ocular Disease and Trauma
Janis T. Eells, Ph.D.
Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration
MinuteCE®Sustaining Visual Benefits of Photobiomodulation in Dry Age-Related Macular Degeneration
Marion Munk, MD, Ph.D
David Boyer, MD
Anatomical Outcomes from the LIGHTSITE III Trial
MinuteCE®Anatomical Outcomes from the LIGHTSITE III Trial
Diana V. Do, MD
David Boyer, MD
